Mathematical Model of Clonal Evolution Proposes a Personalised Multi-Modal Therapy for High-Risk Neuroblastoma

SIMPLE SUMMARY: Neuroblastoma is a rare type of cancer that usually affects children. The high-risk patients’ expected survival rate is less than 50%. One reason is the lack of precision in the standard treatment protocol: a one-size-fits-all multi-modal therapy. The study presented in this paper wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Italia, Matteo, Wertheim, Kenneth Y., Taschner-Mandl, Sabine, Walker, Dawn, Dercole, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093626/
https://www.ncbi.nlm.nih.gov/pubmed/37046647
http://dx.doi.org/10.3390/cancers15071986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093626/
https://www.ncbi.nlm.nih.gov/pubmed/37046647
http://dx.doi.org/10.3390/cancers15071986

Ejemplares similares